Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALSOG - FR0000065864 - Common Stock

28.2 EUR
-0.1 (-0.35%)
Last: 1/13/2026, 7:00:00 PM
Fundamental Rating

6

Overall ALSOG gets a fundamental rating of 6 out of 10. We evaluated ALSOG against 54 industry peers in the Aerospace & Defense industry. ALSOG is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALSOG. These ratings could make ALSOG a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ALSOG had positive earnings in the past year.
In the past year ALSOG had a positive cash flow from operations.
ALSOG had positive earnings in 4 of the past 5 years.
In the past 5 years ALSOG always reported a positive cash flow from operatings.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of ALSOG (3.53%) is comparable to the rest of the industry.
ALSOG's Return On Equity of 11.09% is in line compared to the rest of the industry. ALSOG outperforms 50.00% of its industry peers.
With a decent Return On Invested Capital value of 9.75%, ALSOG is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALSOG is below the industry average of 9.28%.
The last Return On Invested Capital (9.75%) for ALSOG is above the 3 year average (6.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.53%
ROE 11.09%
ROIC 9.75%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Profit Margin of ALSOG (3.17%) is worse than 64.81% of its industry peers.
ALSOG's Profit Margin has improved in the last couple of years.
ALSOG has a Operating Margin of 5.80%. This is in the lower half of the industry: ALSOG underperforms 72.22% of its industry peers.
ALSOG's Operating Margin has improved in the last couple of years.
ALSOG's Gross Margin of 59.16% is amongst the best of the industry. ALSOG outperforms 87.04% of its industry peers.
ALSOG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

7

2. Health

2.1 Basic Checks

ALSOG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALSOG remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ALSOG has an improved debt to assets ratio.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALSOG has an Altman-Z score of 2.56. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
ALSOG has a Altman-Z score (2.56) which is in line with its industry peers.
The Debt to FCF ratio of ALSOG is 1.39, which is an excellent value as it means it would take ALSOG, only 1.39 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.39, ALSOG belongs to the best of the industry, outperforming 90.74% of the companies in the same industry.
ALSOG has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
ALSOG has a Debt to Equity ratio of 0.44. This is in the better half of the industry: ALSOG outperforms 62.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Altman-Z 2.56
ROIC/WACC1.18
WACC8.23%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALSOG has a Current Ratio of 1.66. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
ALSOG has a Current ratio of 1.66. This is in the better half of the industry: ALSOG outperforms 77.78% of its industry peers.
A Quick Ratio of 1.41 indicates that ALSOG should not have too much problems paying its short term obligations.
The Quick ratio of ALSOG (1.41) is better than 81.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.41
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.00% over the past year.
The Earnings Per Share has been growing by 18.82% on average over the past years. This is quite good.
ALSOG shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
The Revenue has been growing by 9.06% on average over the past years. This is quite good.
EPS 1Y (TTM)76%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%

3.2 Future

Based on estimates for the next years, ALSOG will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.42% on average per year.
ALSOG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.01% yearly.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.09 indicates a rather expensive valuation of ALSOG.
Based on the Price/Earnings ratio, ALSOG is valued cheaper than 98.15% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. ALSOG is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 10.86 indicates a reasonable valuation of ALSOG.
Based on the Price/Forward Earnings ratio, ALSOG is valued cheaper than 98.15% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, ALSOG is valued rather cheaply.
Industry RankSector Rank
PE 17.09
Fwd PE 10.86
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALSOG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ALSOG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.5
EV/EBITDA 8.05
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ALSOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSOG has a very decent profitability rating, which may justify a higher PE ratio.
ALSOG's earnings are expected to grow with 18.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%

5

5. Dividend

5.1 Amount

ALSOG has a Yearly Dividend Yield of 3.48%.
ALSOG's Dividend Yield is rather good when compared to the industry average which is at 0.77. ALSOG pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, ALSOG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ALSOG pays out 58.56% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.56%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (1/13/2026, 7:00:00 PM)

28.2

-0.1 (-0.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-29 2025-10-29
Earnings (Next)01-28 2026-01-28
Inst Owners4.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap90.24M
Revenue(TTM)158.49M
Net Income(TTM)5.03M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.48%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP58.56%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.09
Fwd PE 10.86
P/S 0.57
P/FCF 4.5
P/OCF 4.23
P/B 1.99
P/tB 3.67
EV/EBITDA 8.05
EPS(TTM)1.65
EY5.85%
EPS(NY)2.6
Fwd EY9.21%
FCF(TTM)6.26
FCFY22.2%
OCF(TTM)6.66
OCFY23.63%
SpS49.53
BVpS14.16
TBVpS7.68
PEG (NY)0.64
PEG (5Y)N/A
Graham Number22.93
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 11.09%
ROCE 11.28%
ROIC 9.75%
ROICexc 12.05%
ROICexgc 17.44%
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
FCFM 12.64%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexgc growth 3Y2.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Debt/EBITDA 1.61
Cap/Depr 38.36%
Cap/Sales 0.81%
Interest Coverage 9.7
Cash Conversion 169.91%
Profit Quality 398.63%
Current Ratio 1.66
Quick Ratio 1.41
Altman-Z 2.56
F-Score8
WACC8.23%
ROIC/WACC1.18
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y48.67%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y977.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y778.17%
OCF growth 3Y101.39%
OCF growth 5YN/A

SOGECLAIR / ALSOG.PA FAQ

What is the fundamental rating for ALSOG stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALSOG.PA.


Can you provide the valuation status for SOGECLAIR?

ChartMill assigns a valuation rating of 8 / 10 to SOGECLAIR (ALSOG.PA). This can be considered as Undervalued.


What is the profitability of ALSOG stock?

SOGECLAIR (ALSOG.PA) has a profitability rating of 6 / 10.


What is the valuation of SOGECLAIR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SOGECLAIR (ALSOG.PA) is 17.09 and the Price/Book (PB) ratio is 1.99.


Can you provide the dividend sustainability for ALSOG stock?

The dividend rating of SOGECLAIR (ALSOG.PA) is 5 / 10 and the dividend payout ratio is 58.56%.